查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1840860

傷口縫合器械市場：按產品類型、傷口類型、用途、應用、病患小組、最終用戶和分銷管道分類——2025-2030年全球預測

Wound Closure Devices Market by Product Type, Wound Type, Usability, Application, Patient Group, End User, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2030 年，傷口縫合裝置市場規模將達到 222.7 億美元，年複合成長率為 6.91%。

關鍵市場統計數據
基準年 2024 149.1億美元
預計年份：2025年 159.1億美元
預測年份 2030 222.7億美元
複合年成長率 (%) 6.91%

全面說明影響現代醫療保健服務中傷口縫合裝置選擇和創新的臨床和營運促進因素

由於臨床需求的變化、生物材料的進步以及新型器械的人體工學設計，傷口縫合器械領域正在迅速發展。本文概述了目前的研究現狀，介紹了主要產品類型、典型治療場景以及影響器械應用的臨床因素。此外，本文還闡述了器械的選擇如何日益受到手術類型、患者併發症以及在保證安全性和美容效果的同時提高手術效率的需求等因素的影響。

過去幾年，臨床醫生一直在尋求兼具易用性和可靠性的解決方案，這推動了止血鉗、縫合釘、手術膠帶、縫合線、組織黏合劑等產品的種類日益豐富。同時，支付方和醫療服務提供者則致力於控制成本和減少後續併發症，因此更加重視能夠縮短手術時間、降低感染風險並實現門診管理的醫療技術。此外，監管機構日益重視臨床證據和上市後監測，進一步加劇了這些動態，促使製造商加強對資料收集和產品迭代改進的投入。

本節闡述了臨床趨勢、營運限制和材料創新如何影響採購決策和產品開發重點，為後續分析奠定了基礎。此外，本節還預測了市場區隔、區域差異、關稅和競爭定位如何為整個生態系統中的相關人員創造策略選擇。

生物材料、器械人體工學、門診手術流程轉變以及實證醫學需求等方面的進步，正在如何改變傷口縫合器械的策略和應用。

材料科學的突破、門診手術的普及以及對兼顧臨床療效和醫療服務效率的解決方案的需求，正推動傷口縫合器械領域發生顯著變化。生物聚合物和合成黏合劑的創新拓展了組織黏合劑的功能範圍，使其能夠應用於包括皮膚科、外科和急診醫學在內的眾多領域。同時，動力縫合系統和先進的止血劑正在重新定義術中效率，並促使人們重新評估傳統器械的選擇。

手術流程向門診手術中心和日間診所的轉移，加速了對能夠快速應用、降低併發症發生率並簡化庫存管理的醫療器械的需求。這種轉變也促使製造商設計出具有更高貨架穩定性並簡化培訓要求的產品。同時，監管機構對強而有力的臨床證據和上市後監測的要求，也促使企業用對比數據、真實世界證據和病患報告結果來支持其產品聲明。這些因素共同推動了規模較小、缺乏資金開展大規模臨床項目的公司的整合，同時也使更靈活的新進入者能夠憑藉專業的粘合劑化學技術和新型止血配方，搶佔臨床細分市場。

展望未來，與數位健康平台的互通性、減少臨床醫生疲勞的程序人體工學以及耗材設計中的永續性考慮等因素可能會進一步影響採用模式，而參與企業可能會獲得永續的競爭優勢。

在整個傷口縫合器械生態系統中，預期的關稅變化將重塑供應鏈、籌資策略和採購談判。

預計2025年的關稅波動將為依賴全球供應鏈獲取耗材和資本設備的製造商、經銷商和醫療保健系統帶來更多複雜性。進口關稅波動可能會改變製造業的經濟效益，促使零件生產向近岸地區轉移，並影響醫院和診所層級的定價策略。如果某些投入品或成品的關稅增加，製造商必須評估是否自行承擔成本、將其轉嫁給買家，還是重組供應鏈以緩解利潤壓力。

對此，一些製造商可能會加強實現關鍵零件的在地化採購，並與供應商協商簽訂多年協議以穩定原料成本。經銷商和集團採購組織可能會重新評估框架協議，並採用基於採購量的合約來保護其成員免受價格波動的影響。對於醫療服務提供者而言，不斷上漲的採購成本可能會加速其轉向成本更低的替代方案，促使其加強醫療資源利用管理，或鼓勵其投資於能夠顯著縮短手術時間和降低併發症相關成本的設備。

此外，關稅引發的成本波動可能會刺激策略性併購活動，因為企業尋求擴大規模以吸收宏觀經濟衝擊並確保製造地的韌性。整體而言，關稅的累積影響將波及定價、採購和供應鏈韌性策略，迫使相關人員更深入了解單位經濟效益和區域採購依賴。

詳細的細分揭示了不同產品類型、臨床應用、最終用戶和材料分類的創新重點，從而影響產品的採納和採購。

細分市場層面的動態變化揭示了不同產品類型、應用、最終用戶和材料分類所帶來的差異化成長和市場接受度促進因素。以產品類型為基礎的生態系統包括：止血劑（包括明膠海綿、氧化再生纖維素和多醣止血劑）；縫合釘（分為手動和電動）；醫用膠帶（分為微孔和透明）；縫合線（分為可吸收和不可吸收）；以及組織黏合劑（包括白蛋白生物聚合物、氰基丙烯酸酯和纖維製劑）。止血劑著重於改進配方和給藥方式；縫合釘著重於器械的人體工學設計和一致性；膠帶著重於黏合性和皮膚耐受性；縫線著重於平衡拉伸強度和吸收性能；而黏合劑則致力於加快固化速度和提高組織相容性。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 可吸收縫線的日益普及，使得手術縫合速度更快，打結也更加複雜。
  • 為了最大限度地降低術後感染率，使用三氯生塗層抗菌縫線的情況越來越多。
  • 擴大組織黏合技術在微創手術的應用，提升病患舒適度
  • 將生物感測器和智慧傷口縫合系統整合起來，用於即時癒合監測和數據分析。
  • 人們對雷射組織焊接技術越來越感興趣，該技術可以減少熱損傷並促進止血。
  • 開發一種用於傷口縫合的可生物分解縫合釘，無需二次取出手術。
  • 提高複雜外科手術精準度的機器人縫合工具需求激增
  • 手術室中出現了具有人工智慧引導切割和密封功能的自動傷口縫合裝置
  • 加強醫療器材製造商和數位醫療公司之間的合作，以實現遠距傷口評估

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 按產品類型傷口縫合器材市場

  • 黏合劑和組織密封膠
    • 封條和膠帶
    • 膠原蛋白基密封劑
    • 氰基丙烯酸酯黏合劑
    • 纖維蛋白膠
  • 機械設備
    • 組織擴張器
    • 傷口縫合系統
  • 訂書機
    • 手動訂書機
    • 電動訂書機
  • 縫合線
    • 吸收性
    • 不可吸收

第9章 按傷口類型分類的傷口縫合器材市場

  • 急性傷口
    • 手術切口
    • 創傷
  • 慢性傷口
    • 動脈潰瘍
    • 糖尿病潰瘍
    • 壓瘡
    • 靜脈潰瘍

第10章傷口縫合器械市場：依用途分類

  • 一次性的
  • 可重複使用的

第11章傷口縫合器械市場：依應用領域分類

  • 心胸外科
  • 整形外科
  • 口腔顎顏面外科
  • 急診醫學與創傷
  • 胃腸和大腸直腸外科
  • 一般外科
  • 神經外科
  • 婦產科
  • 眼科手術
  • 整形外科
  • 血管外科

第12章傷口縫合器械市場：病患小組

  • 成人
  • 老年人
  • 孩子們

第13章 按最終用戶傷口縫合器械市場

  • 門診手術中心
  • 家庭醫療保健
  • 醫院
  • 創傷中心

第14章 按分銷管道分類的傷口縫合器械市場

  • 離線
  • 線上
    • 品牌網站
    • 電子商務平台

第15章 各地區傷口縫合器械市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章傷口縫合器械市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章 各國傷口縫合器材市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • 3M Company
    • Smith+Nephew plc
    • B. Braun SE
    • Baxter International Inc.
    • Boston Scientific Corporation
    • Coloplast A/S
    • Essity AB
    • Johnson & Johnson Services, Inc.
    • Medtronic plc
    • Stryker Corporation
    • Teleflex Incorporated.
    • Zimmer Biomet Holdings, Inc.
Product Code: MRR-221461476F5D

The Wound Closure Devices Market is projected to grow by USD 22.27 billion at a CAGR of 6.91% by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 14.91 billion
Estimated Year [2025] USD 15.91 billion
Forecast Year [2030] USD 22.27 billion
CAGR (%) 6.91%

A comprehensive orientation to the clinical and operational drivers that are reshaping wound closure device choice and innovation in contemporary healthcare delivery

The wound closure device space is evolving rapidly, shaped by shifting clinical priorities, advances in biomaterials, and novel device ergonomics. This introduction frames the current landscape by describing the primary product modalities, typical care settings, and the clinical drivers that influence adoption. It outlines how device selection is increasingly influenced by procedure type, patient comorbidity profiles, and the need to accelerate throughput while maintaining safety and cosmetic outcomes.

Over recent years, clinicians have sought solutions that balance ease of use with reliable performance, and this has encouraged diversification across hemostats, staples, surgical tapes, sutures, and tissue adhesives. Concurrently, payers and providers are focused on cost containment and reducing downstream complications, which places a premium on technologies that reduce procedure time, minimize infection risk, and enable outpatient management. These dynamics are compounded by a heightened regulatory emphasis on clinical evidence and post-market surveillance, prompting manufacturers to invest in data generation and iterative product improvements.

This section establishes the foundational context for the subsequent analysis, explaining how clinical trends, operational constraints, and material innovations converge to shape procurement decisions and product development priorities. It also previews how segmentation, regional variations, tariffs, and competitive positioning inform strategic options for stakeholders across the ecosystem.

How advances in biomaterials, device ergonomics, outpatient procedural shifts, and evidence demands are jointly transforming wound closure device strategy and adoption

The landscape for wound closure devices is undergoing transformative shifts driven by material science breakthroughs, procedural migration to ambulatory settings, and demand for solutions that optimize both clinical outcomes and provider efficiency. Innovations in biopolymers and synthetic adhesives have expanded the functional envelope of tissue adhesives, enabling broader application across dermatologic, surgical, and emergency care. At the same time, powered stapling systems and advanced hemostatic agents are redefining intraoperative efficiency, prompting re-evaluation of traditional device choices.

Procedural migration toward ambulatory surgical centers and outpatient clinics has accelerated the need for devices that support rapid application, low complication rates, and simplified inventory management. This shift is also encouraging manufacturers to design products with improved shelf stability and simplified training requirements. In parallel, regulatory expectations for robust clinical evidence and post-market surveillance are pushing companies to augment product claims with comparative data, real-world evidence, and patient-reported outcomes. These combined forces are catalyzing consolidation among mid-sized players that lack scale to fund extensive clinical programs, while enabling nimble entrants to capture niche clinical segments through specialized adhesive chemistries or novel hemostatic formulations.

Looking ahead, interoperability with digital health platforms, procedural ergonomics that reduce clinician fatigue, and sustainability considerations in consumable design will further influence adoption patterns, with early movers likely to secure durable competitive advantages.

Anticipated tariff shifts will compel reconfiguration of supply chains, sourcing strategies, and procurement negotiations across the wound closure device ecosystem

Anticipated tariff changes in 2025 introduce an additional layer of complexity for manufacturers, distributors, and health systems that rely on global supply chains for consumables and capital equipment. Shifts in import duties can alter manufacturing economics, incentivize nearshoring of component production, and influence pricing strategies at both the hospital and clinic levels. When tariffs increase on specific inputs or finished goods, manufacturers must evaluate whether to absorb costs, pass them to buyers, or reconfigure supply chains to mitigate margin pressure.

In response, several manufacturers are likely to intensify efforts to localize critical component sourcing and to negotiate multi-year supplier agreements to stabilize input costs. Distributors and group purchasing organizations may reassess framework agreements and leverage volume-based contracting to buffer members from price volatility. For providers, elevated acquisition costs could accelerate substitution toward lower-cost alternatives, encourage stricter utilization management, or prompt investments in devices that demonstrate clear reductions in procedure time and complication-related expenses.

Moreover, tariff-induced cost variability may spur strategic M&A activity as companies seek scale to absorb macroeconomic shocks and to secure manufacturing footprint resilience. Overall, the cumulative impact of tariffs will be felt across pricing, procurement, and supply resilience strategies, compelling stakeholders to adopt a more granular view of unit economics and regional sourcing dependencies.

Detailed segmentation reveals distinct innovation priorities across product types, clinical applications, end users, and material classifications shaping adoption and procurement

Segment-level dynamics reveal differentiated growth and adoption drivers across product types, applications, end users, and material classifications. Based on Product Type, the ecosystem comprises Hemostats with gelatin sponges, oxidized regenerated cellulose, and polysaccharide hemostats; Staples split into manual and powered variants; Surgical Tapes categorized as microporous and transparent; Sutures divided into absorbable and nonabsorbable types; and Tissue Adhesives that include albumin biopolymer, cyanoacrylate, and fibrin formulations. Each product cluster follows its own innovation cadence: hemostats lean heavily on formulation and delivery improvements, staples emphasize device ergonomics and consistency, tapes focus on adhesion and skin tolerance, sutures balance tensile strength with absorption profiles, and adhesives pursue faster set times and improved tissue compatibility.

Based on Application, product selection and design priorities vary significantly across cosmetic, dental, emergency, and surgical settings. Cosmetic procedures prioritize minimal scarring and superior aesthetic outcomes, dental applications demand moisture-tolerant adhesives and compact delivery, emergency care emphasizes speed and ease of application, and surgical procedures require products that meet intraoperative sterility and tensile requirements. These application-level differences manifest in packaging formats, regulatory evidence strategies, and clinician training programs.

Based on End User, adoption dynamics differ across ambulatory surgical centers, clinics, home healthcare, and hospitals. Ambulatory centers and clinics favor solutions that reduce turnover time and support high procedural throughput, while hospitals value devices that integrate with surgical workflows and accommodate diverse case complexity. Home healthcare trends are driving interest in long-wear adhesives and simplified suturing alternatives that support remote care. Based on Material, the distinction between absorbable and nonabsorbable materials remains a critical determinant of product selection, influencing healing trajectories, follow-up requirements, and reimbursement considerations.

Regional variations in regulation, reimbursement, and care delivery across three global zones are determining differentiated adoption pathways for wound closure innovations

Regional dynamics shape both adoption pathways and competitive positioning across the Americas, Europe Middle East and Africa, and Asia Pacific, each presenting unique regulatory, reimbursement, and care delivery contexts. In the Americas, clinical practice patterns are influenced by a mix of well-resourced tertiary centers and high-volume ambulatory facilities, creating demand for both premium, evidence-backed devices and cost-efficient consumables that support outpatient throughput. Reimbursement and procurement mechanisms tend to favor demonstrable outcome improvements, which benefits technologies that reduce length of stay or complication rates.

In Europe, the Middle East and Africa region, heterogeneity is significant: established markets prioritize rigorous clinical evidence and centralized procurement processes, while emerging markets emphasize affordability and supply-chain resilience. Regulatory frameworks across this region vary, affecting time to adoption and the commercial approach required for market entry. The Asia Pacific region demonstrates rapid adoption of novel adhesives and simplified closure systems in both urban hospitals and growing ambulatory networks. Local manufacturing capacity and government initiatives to strengthen domestic supply chains accelerate product localization and partnerships between multinational companies and regional manufacturers.

Across all regions, cross-border sourcing, regulatory harmonization efforts, and localized clinical evidence generation will influence how quickly innovations diffuse into practice. Manufacturers should therefore tailor go-to-market strategies to regional reimbursement norms, clinician training expectations, and distribution channel structures to maximize adoption.

Competitive positioning is being defined by scale for evidence investment, niche innovation for clinical differentiation, and strategic partnerships to expand distribution

Competitive dynamics within the wound closure device landscape are shaped by several leading and specialized companies that invest in product development, clinical evidence, and distribution networks. Incumbents with broad portfolios leverage scale to fund clinical trials, maintain extensive sales and training infrastructures, and negotiate preferred-supplier status with large health systems. These firms often prioritize incremental product improvements and platform extensions to preserve share across multiple closure categories.

Conversely, smaller and mid-sized firms tend to focus on niche innovations-unique adhesive chemistries, single-use powered instruments, or advanced hemostatic formulations-to capture clinical mindshare and create acquisition interest. Startups frequently pursue strategic partnerships with established manufacturers to access regulatory expertise and global distribution. Additionally, contract manufacturers and component suppliers play a critical role by enabling rapid prototyping and flexible production scaling, which is especially important when manufacturers face tariff-driven incentives to regionalize production.

Across the competitive set, differentiation increasingly rests on the ability to demonstrate real-world benefits, streamline clinician training, and offer integrated value propositions that combine product, training, and post-market surveillance. Strategic alliances, selective acquisitions, and targeted clinical investments will continue to define competitive positioning over the near term.

Actionable strategic priorities for leaders to align clinical evidence, supply-chain resilience, and commercial execution to accelerate adoption and reduce risk

Industry leaders should pursue an integrated approach that aligns R&D priorities with procurement realities, supply-chain resilience, and clinician adoption pathways. First, invest in clinical evidence that addresses both efficacy and health economic endpoints to demonstrate value across inpatient and outpatient settings. This evidence should include procedure time comparisons, complication reduction metrics, and patient-reported outcomes that resonate with payers and health system decision-makers. Second, prioritize supply-chain diversification by establishing regional manufacturing nodes and qualifying alternate suppliers for critical inputs to reduce exposure to tariff and logistics shocks.

Third, optimize product portfolios to offer clear differentiation: simplify training and packaging for point-of-care users while advancing material science for high-acuity surgical indications. Fourth, enhance go-to-market models with targeted education programs for ambulatory and home healthcare clinicians, supplemented by digital learning platforms and procedural simulations. Fifth, explore commercial partnerships and selective acquisitions that accelerate access to local distribution networks, particularly in regions where regulatory pathways and procurement preferences favor domestic partnerships. Finally, incorporate environmental and sustainability metrics into product development and packaging decisions to address growing institutional procurement requirements and to position offerings favorably among socially responsible purchasers.

Transparent and reproducible research methodology combining clinician interviews, regulatory review, clinical literature, and supply-chain analysis to inform strategic conclusions

The research underpinning this analysis integrates multiple primary and secondary inputs, with a focus on ensuring transparency, reproducibility, and alignment to clinical practice. Primary research included structured interviews with clinicians across surgical specialties, procurement leaders at hospital systems and ambulatory centers, and supply-chain executives responsible for device sourcing. These interviews provided qualitative insights on clinician preferences, procurement triggers, and the operational trade-offs that shape device choice.

Secondary inputs comprised peer-reviewed clinical literature on wound closure outcomes, regulatory guidance documents, product labeling and instructions for use, and public financial disclosures that shed light on strategic investments and manufacturing footprints. Data synthesis involved triangulating clinical preferences with procurement priorities and manufacturing realities to identify actionable implications. Where applicable, scenario analysis was used to assess the operational impact of tariff changes and supply-chain disruption, and sensitivity checks validated the robustness of conclusions. Throughout, emphasis was placed on distinguishing between clinically meaningful innovations and incremental product changes that have limited impact on care pathways.

A synthesis of how innovation, procurement pressures, and supply-chain shifts will determine winners in the evolving clinical and commercial wound closure ecosystem

In conclusion, the wound closure device landscape is at an inflection point where material innovation, outpatient procedural growth, and supply-chain reconfiguration are converging to reshape clinical practice and commercial imperatives. Manufacturers and health systems that prioritize rigorous clinical evidence, regional supply resilience, and differentiated product experiences will be best positioned to capture emerging opportunities. The interplay between tariff pressures and localization incentives will particularly influence production decisions and distribution strategies, urging stakeholders to adopt proactive sourcing and contract negotiation approaches.

Providers will continue to prioritize devices that demonstrate tangible improvements in throughput, patient outcomes, and overall episode cost, while innovators should align product development with these practical priorities. Competitive dynamics will favor organizations that can combine the resources to support expansive clinical programs with the agility to develop highly targeted solutions for specific applications. Moving forward, success will hinge on the ability to translate technical innovation into operational value that resonates with clinicians, payers, and procurement leaders across diverse regional contexts.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increasing adoption of absorbable barbed sutures for faster surgical closure and reduced knot tying complexity
  • 5.2. Growth in the use of antimicrobial sutures with triclosan coating to minimize postoperative infection rates
  • 5.3. Expansion of tissue adhesive applications for minimally invasive procedures and improved patient comfort
  • 5.4. Integration of smart wound closure systems with biosensors for real-time healing monitoring and data analytics
  • 5.5. Rising preference for laser tissue welding technologies to reduce thermal damage and accelerate hemostasis
  • 5.6. Development of biodegradable staples for internal wound closure to eliminate secondary removal procedures
  • 5.7. Surge in demand for robotic-assisted suturing tools improving precision in complex surgical interventions
  • 5.8. Emergence of automated wound closure devices with AI-guided cut and seal capabilities in operating theaters
  • 5.9. Increasing collaboration between device manufacturers and digital health firms to enable remote wound assessment
  • 5.10. Introduction of multifunctional hydrogel patches combining hemostatic, antimicrobial, and tissue regenerative properties

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Wound Closure Devices Market, by Product Type

  • 8.1. Adhesives & Tissue Sealants
    • 8.1.1. Closure Strips & Tapes
    • 8.1.2. Collagen-Based Sealants
    • 8.1.3. Cyanoacrylate Adhesives
    • 8.1.4. Fibrin Sealants
  • 8.2. Mechanical Devices
    • 8.2.1. Tissue Expanders
    • 8.2.2. Wound Closure Systems
  • 8.3. Staplers
    • 8.3.1. Manual Staplers
    • 8.3.2. Powered Staplers
  • 8.4. Sutures
    • 8.4.1. Absorbable
    • 8.4.2. Non-Absorbable

9. Wound Closure Devices Market, by Wound Type

  • 9.1. Acute Wounds
    • 9.1.1. Surgical Incisions
    • 9.1.2. Traumatic Injuries
  • 9.2. Chronic Wounds
    • 9.2.1. Arterial Ulcers
    • 9.2.2. Diabetic Ulcers
    • 9.2.3. Pressure Ulcers
    • 9.2.4. Venous Ulcers

10. Wound Closure Devices Market, by Usability

  • 10.1. Disposable
  • 10.2. Reusable

11. Wound Closure Devices Market, by Application

  • 11.1. Cardiothoracic Surgery
  • 11.2. Cosmetic & Plastic Surgery
  • 11.3. Dental & Maxillofacial Surgery
  • 11.4. Emergency Medicine & Trauma
  • 11.5. Gastrointestinal & Colorectal Surgery
  • 11.6. General Surgery
  • 11.7. Neurosurgery
  • 11.8. Obstetrics & Gynecology
  • 11.9. Ophthalmic Surgery
  • 11.10. Orthopedic Surgery
  • 11.11. Vascular Surgery

12. Wound Closure Devices Market, by Patient Group

  • 12.1. Adult
  • 12.2. Geriatric
  • 12.3. Pediatric

13. Wound Closure Devices Market, by End User

  • 13.1. Ambulatory Surgical Centers
  • 13.2. Home Healthcare
  • 13.3. Hospitals
  • 13.4. Trauma Centers

14. Wound Closure Devices Market, by Distribution Channel

  • 14.1. Offline
  • 14.2. Online
    • 14.2.1. Brand Websites
    • 14.2.2. eCommerce Platform

15. Wound Closure Devices Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Wound Closure Devices Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Wound Closure Devices Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. Competitive Landscape

  • 18.1. Market Share Analysis, 2024
  • 18.2. FPNV Positioning Matrix, 2024
  • 18.3. Competitive Analysis
    • 18.3.1. 3M Company
    • 18.3.2. Smith+Nephew plc
    • 18.3.3. B. Braun SE
    • 18.3.4. Baxter International Inc.
    • 18.3.5. Boston Scientific Corporation
    • 18.3.6. Coloplast A/S
    • 18.3.7. Essity AB
    • 18.3.8. Johnson & Johnson Services, Inc.
    • 18.3.9. Medtronic plc
    • 18.3.10. Stryker Corporation
    • 18.3.11. Teleflex Incorporated.
    • 18.3.12. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 2. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 3. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY WOUND TYPE, 2024 VS 2030 (%)
  • FIGURE 5. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY WOUND TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY USABILITY, 2024 VS 2030 (%)
  • FIGURE 7. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY USABILITY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY PATIENT GROUP, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY PATIENT GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS WOUND CLOSURE DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. NORTH AMERICA WOUND CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. LATIN AMERICA WOUND CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA WOUND CLOSURE DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE WOUND CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. MIDDLE EAST WOUND CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 23. AFRICA WOUND CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC WOUND CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 25. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. ASEAN WOUND CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 27. GCC WOUND CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 28. EUROPEAN UNION WOUND CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 29. BRICS WOUND CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 30. G7 WOUND CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 31. NATO WOUND CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 32. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 33. WOUND CLOSURE DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 34. WOUND CLOSURE DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. WOUND CLOSURE DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ADHESIVES & TISSUE SEALANTS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ADHESIVES & TISSUE SEALANTS, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ADHESIVES & TISSUE SEALANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ADHESIVES & TISSUE SEALANTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ADHESIVES & TISSUE SEALANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ADHESIVES & TISSUE SEALANTS, BY GROUP, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ADHESIVES & TISSUE SEALANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ADHESIVES & TISSUE SEALANTS, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY CLOSURE STRIPS & TAPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY CLOSURE STRIPS & TAPES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY CLOSURE STRIPS & TAPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY CLOSURE STRIPS & TAPES, BY GROUP, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY CLOSURE STRIPS & TAPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY CLOSURE STRIPS & TAPES, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY COLLAGEN-BASED SEALANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY COLLAGEN-BASED SEALANTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY COLLAGEN-BASED SEALANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY COLLAGEN-BASED SEALANTS, BY GROUP, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY COLLAGEN-BASED SEALANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY COLLAGEN-BASED SEALANTS, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY CYANOACRYLATE ADHESIVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY CYANOACRYLATE ADHESIVES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY CYANOACRYLATE ADHESIVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY CYANOACRYLATE ADHESIVES, BY GROUP, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY CYANOACRYLATE ADHESIVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY CYANOACRYLATE ADHESIVES, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY FIBRIN SEALANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY FIBRIN SEALANTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY FIBRIN SEALANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY FIBRIN SEALANTS, BY GROUP, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY FIBRIN SEALANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY FIBRIN SEALANTS, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY MECHANICAL DEVICES, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY MECHANICAL DEVICES, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY MECHANICAL DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY MECHANICAL DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY MECHANICAL DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY MECHANICAL DEVICES, BY GROUP, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY MECHANICAL DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY MECHANICAL DEVICES, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY TISSUE EXPANDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY TISSUE EXPANDERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY TISSUE EXPANDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY TISSUE EXPANDERS, BY GROUP, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY TISSUE EXPANDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY TISSUE EXPANDERS, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY WOUND CLOSURE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY WOUND CLOSURE SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY WOUND CLOSURE SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY WOUND CLOSURE SYSTEMS, BY GROUP, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY WOUND CLOSURE SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY WOUND CLOSURE SYSTEMS, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY STAPLERS, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY STAPLERS, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY STAPLERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY STAPLERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY STAPLERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY STAPLERS, BY GROUP, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY STAPLERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY STAPLERS, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY MANUAL STAPLERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY MANUAL STAPLERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY MANUAL STAPLERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY MANUAL STAPLERS, BY GROUP, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY MANUAL STAPLERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY MANUAL STAPLERS, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY POWERED STAPLERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY POWERED STAPLERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 75. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY POWERED STAPLERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY POWERED STAPLERS, BY GROUP, 2025-2030 (USD MILLION)
  • TABLE 77. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY POWERED STAPLERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY POWERED STAPLERS, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 79. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY SUTURES, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY SUTURES, 2025-2030 (USD MILLION)
  • TABLE 81. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY SUTURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY SUTURES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 83. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY SUTURES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY SUTURES, BY GROUP, 2025-2030 (USD MILLION)
  • TABLE 85. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY SUTURES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY SUTURES, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 87. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ABSORBABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ABSORBABLE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 89. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ABSORBABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ABSORBABLE, BY GROUP, 2025-2030 (USD MILLION)
  • TABLE 91. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ABSORBABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ABSORBABLE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 93. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY NON-ABSORBABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY NON-ABSORBABLE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 95. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY NON-ABSORBABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY NON-ABSORBABLE, BY GROUP, 2025-2030 (USD MILLION)
  • TABLE 97. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY NON-ABSORBABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY NON-ABSORBABLE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 99. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY WOUND TYPE, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY WOUND TYPE, 2025-2030 (USD MILLION)
  • TABLE 101. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ACUTE WOUNDS, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ACUTE WOUNDS, 2025-2030 (USD MILLION)
  • TABLE 103. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ACUTE WOUNDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ACUTE WOUNDS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 105. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ACUTE WOUNDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ACUTE WOUNDS, BY GROUP, 2025-2030 (USD MILLION)
  • TABLE 107. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ACUTE WOUNDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ACUTE WOUNDS, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 109. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY SURGICAL INCISIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY SURGICAL INCISIONS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 111. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY SURGICAL INCISIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY SURGICAL INCISIONS, BY GROUP, 2025-2030 (USD MILLION)
  • TABLE 113. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY SURGICAL INCISIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY SURGICAL INCISIONS, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 115. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY TRAUMATIC INJURIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY TRAUMATIC INJURIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 117. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY TRAUMATIC INJURIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY TRAUMATIC INJURIES, BY GROUP, 2025-2030 (USD MILLION)
  • TABLE 119. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY TRAUMATIC INJURIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY TRAUMATIC INJURIES, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 121. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY CHRONIC WOUNDS, 2025-2030 (USD MILLION)
  • TABLE 123. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY CHRONIC WOUNDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY CHRONIC WOUNDS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 125. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY CHRONIC WOUNDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY CHRONIC WOUNDS, BY GROUP, 2025-2030 (USD MILLION)
  • TABLE 127. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY CHRONIC WOUNDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY CHRONIC WOUNDS, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 129. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ARTERIAL ULCERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ARTERIAL ULCERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 131. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ARTERIAL ULCERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ARTERIAL ULCERS, BY GROUP, 2025-2030 (USD MILLION)
  • TABLE 133. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ARTERIAL ULCERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ARTERIAL ULCERS, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 135. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY DIABETIC ULCERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY DIABETIC ULCERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 137. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY DIABETIC ULCERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY DIABETIC ULCERS, BY GROUP, 2025-2030 (USD MILLION)
  • TABLE 139. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY DIABETIC ULCERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY DIABETIC ULCERS, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 141. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY PRESSURE ULCERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY PRESSURE ULCERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 143. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY PRESSURE ULCERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY PRESSURE ULCERS, BY GROUP, 2025-2030 (USD MILLION)
  • TABLE 145. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY PRESSURE ULCERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY PRESSURE ULCERS, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 147. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY VENOUS ULCERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY VENOUS ULCERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 149. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY VENOUS ULCERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY VENOUS ULCERS, BY GROUP, 2025-2030 (USD MILLION)
  • TABLE 151. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY VENOUS ULCERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY VENOUS ULCERS, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 153. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY USABILITY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY USABILITY, 2025-2030 (USD MILLION)
  • TABLE 155. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY DISPOSABLE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 157. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY DISPOSABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY DISPOSABLE, BY GROUP, 2025-2030 (USD MILLION)
  • TABLE 159. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 161. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY REUSABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY REUSABLE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 163. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY REUSABLE, BY GROUP, 2025-2030 (USD MILLION)
  • TABLE 165. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY REUSABLE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 167. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 169. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY CARDIOTHORACIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY CARDIOTHORACIC SURGERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 171. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY CARDIOTHORACIC SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY CARDIOTHORACIC SURGERY, BY GROUP, 2025-2030 (USD MILLION)
  • TABLE 173. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY CARDIOTHORACIC SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY CARDIOTHORACIC SURGERY, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 175. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY COSMETIC & PLASTIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY COSMETIC & PLASTIC SURGERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 177. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY COSMETIC & PLASTIC SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY COSMETIC & PLASTIC SURGERY, BY GROUP, 2025-2030 (USD MILLION)
  • TABLE 179. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY COSMETIC & PLASTIC SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY COSMETIC & PLASTIC SURGERY, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 181. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY DENTAL & MAXILLOFACIAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY DENTAL & MAXILLOFACIAL SURGERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 183. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY DENTAL & MAXILLOFACIAL SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY DENTAL & MAXILLOFACIAL SURGERY, BY GROUP, 2025-2030 (USD MILLION)
  • TABLE 185. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY DENTAL & MAXILLOFACIAL SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY DENTAL & MAXILLOFACIAL SURGERY, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 187. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY EMERGENCY MEDICINE & TRAUMA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY EMERGENCY MEDICINE & TRAUMA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 189. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY EMERGENCY MEDICINE & TRAUMA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY EMERGENCY MEDICINE & TRAUMA, BY GROUP, 2025-2030 (USD MILLION)
  • TABLE 191. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY EMERGENCY MEDICINE & TRAUMA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY EMERGENCY MEDICINE & TRAUMA, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 193. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY GASTROINTESTINAL & COLORECTAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY GASTROINTESTINAL & COLORECTAL SURGERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 195. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY GASTROINTESTINAL & COLORECTAL SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY GASTROINTESTINAL & COLORECTAL SURGERY, BY GROUP, 2025-2030 (USD MILLION)
  • TABLE 197. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY GASTROINTESTINAL & COLORECTAL SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY GASTROINTESTINAL & COLORECTAL SURGERY, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 199. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 201. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2025-2030 (USD MILLION)
  • TABLE 203. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 205. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY NEUROSURGERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 207. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY NEUROSURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY NEUROSURGERY, BY GROUP, 2025-2030 (USD MILLION)
  • TABLE 209. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY NEUROSURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY NEUROSURGERY, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 211. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 213. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY GROUP, 2025-2030 (USD MILLION)
  • TABLE 215. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 217. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY OPHTHALMIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY OPHTHALMIC SURGERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 219. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY OPHTHALMIC SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY OPHTHALMIC SURGERY, BY GROUP, 2025-2030 (USD MILLION)
  • TABLE 221. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY OPHTHALMIC SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY OPHTHALMIC SURGERY, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 223. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 225. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2025-2030 (USD MILLION)
  • TABLE 227. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 229. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY VASCULAR SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY VASCULAR SURGERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 231. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY VASCULAR SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY VASCULAR SURGERY, BY GROUP, 2025-2030 (USD MILLION)
  • TABLE 233. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY VASCULAR SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY VASCULAR SURGERY, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 235. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY PATIENT GROUP, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY PATIENT GROUP, 2025-2030 (USD MILLION)
  • TABLE 237. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 239. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ADULT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ADULT, BY GROUP, 2025-2030 (USD MILLION)
  • TABLE 241. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ADULT, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 243. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 245. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY GERIATRIC, BY GROUP, 2025-2030 (USD MILLION)
  • TABLE 247. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 249. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 251. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY PEDIATRIC, BY GROUP, 2025-2030 (USD MILLION)
  • TABLE 253. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 255. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 257. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 259. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2030 (USD MILLION)
  • TABLE 261. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 263. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 265. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2025-2030 (USD MILLION)
  • TABLE 267. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 269. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 271. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2030 (USD MILLION)
  • TABLE 273. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 275. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY TRAUMA CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY TRAUMA CENTERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 277. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY TRAUMA CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY TRAUMA CENTERS, BY GROUP, 2025-2030 (USD MILLION)
  • TABLE 279. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY TRAUMA CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY TRAUMA CENTERS, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 281. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 283. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY OFFLINE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 285. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY OFFLINE, BY GROUP, 2025-2030 (USD MILLION)
  • TABLE 287. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY OFFLINE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 289. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
  • TABLE 291. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 292. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ONLINE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 293. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ONLINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ONLINE, BY GROUP, 2025-2030 (USD MILLION)
  • TABLE 295. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 296. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ONLINE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 297. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY BRAND WEBSITES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 298. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY BRAND WEBSITES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 299. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY BRAND WEBSITES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 300. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY BRAND WEBSITES, BY GROUP, 2025-2030 (USD MILLION)
  • TABLE 301. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY BRAND WEBSITES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 302. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY BRAND WEBSITES, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 303. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ECOMMERCE PLATFORM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 304. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ECOMMERCE PLATFORM, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 305. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ECOMMERCE PLATFORM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 306. GLOBAL WOUND CLOSURE DEVICES MARKET SIZE, BY ECOMMERCE PLATFORM, BY GROUP, 2025-2030 (USD MILLION)

TABLE 30